McGaughy R Kent Jr 4

What happened

• R. Kent McGaughy Jr, a director of Instil Bio, was granted a derivative award for 6,500 shares on 2026-06-11. The filing records an acquisition price of $0.00 (i.e., a grant/option award rather than an open-market purchase or sale). This is an award grant (transaction code A), not a sale.

Key details

• Transaction date: 2026-06-11; Filing date: 2026-06-12 (filed next day).
• Amount: 6,500 shares (derivative award) at $0.00 per share.
• Shares owned after transaction: Not specified in the Form 4 provided.
• Vesting (footnote): The option vests in 12 substantially equal monthly installments beginning July 11, 2026, subject to continuous service. Any unvested portion will vest in full at the next annual stockholder meeting (subject to service). Accelerated vesting occurs upon death, Disability, or a Change in Control.
• No 10b5-1 plan, immediate sale, tax-withholding, or late-filing flag noted in the disclosed items.

Context

• This is a typical director equity grant meant to align long-term incentives; it does not represent an open-market purchase or sale. Because it’s a derivative award with scheduled vesting, the economic benefit is realized over time as installments vest (or sooner if accelerated by specified events).